Most people assume high blood pressure is bad and low blood pressure is good. But in very elderly adults (85+), the picture is more complex. This study examines whether changes in blood pressure might predict or accompany changes in functional ability and cognitive sharpness—a question rarely explored in the oldest-old population.
The researchers analyzed data from 429 participants in the Leiden 85-plus Study, a longitudinal cohort of Dutch adults all aged 85 at baseline. They measured blood pressure, functional status (ability to perform daily tasks), and cognitive function annually for 5 years. Rather than looking at simple correlations, they used a sophisticated statistical method called dynamic time warping (DTW), which can detect lagged relationships between changing variables—essentially asking, 'Does change in X predict change in Y months or years later?'
The main findings: (1) Rising blood pressure over time preceded instrumental activities of daily living (IADL) decline—difficulties with complex tasks like managing finances or medications. Conversely, falling BP preceded IADL improvement. (2) Changes in diastolic blood pressure (the lower number) showed the opposite pattern for cognition: falling diastolic BP preceded cognitive decline on the MMSE test, while rising diastolic BP preceded cognitive improvement. These associations were statistically significant but the paper does not report effect sizes or confidence intervals explicitly in the abstract.
Critical limitations: First, this is observational data in a single cohort; causation cannot be inferred. Second, the sample skews female (69%) and is exclusively Dutch, limiting generalizability. Third, no mechanistic explanation is offered—it is unclear whether BP changes are *causing* functional/cognitive shifts or whether both reflect a shared underlying process (e.g., vascular disease, medication effects, or frailty). Fourth, the paper does not discuss confounders such as antihypertensive medication changes (39% were on such drugs), which could drive both BP and functional/cognitive trajectories independently. Fifth, DTW is a relatively novel epidemiological tool here; the robustness and clinical meaningfulness of the lagged associations are not validated against conventional regression approaches or other cohorts.
For longevity research, this work highlights that in the very oldest adults, BP dynamics may be a more informative biomarker than static BP levels—a hypothesis worth testing prospectively. However, the findings should not change clinical BP targets in the 85+ population, where the evidence for aggressive BP lowering remains uncertain and contested. The results suggest that unexpected BP changes in very old patients warrant clinical attention, but more data on mechanism and replication are needed before drawing firm conclusions.
0 Comments
Log in to join the discussion.